2022
DOI: 10.1016/j.jgg.2021.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Developmental regulation of neuronal gene expression by Elongator complex protein 1 dosage

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 86 publications
0
9
0
Order By: Relevance
“…transcription) functions ( Dalwadi and Yip, 2018 ; Dietrich and Dragatsis, 2016 ; Lefcort et al, 2017 ). To date, animal studies emphasize defects in dorsal root, sympathetic, and enteric ganglia, which relay sensory and autonomic information from the trunk, limbs, and viscera to the CNS ( Abashidze et al, 2014 ; Cheng et al, 2015 ; George et al, 2013 ; Goffena et al, 2018 ; Hunnicutt et al, 2012 ; Jackson et al, 2014 ; Li et al, 2020 ; Morini et al, 2021 ; Tolman et al, 2022 ). However, there is a dearth of knowledge about Elp1 in the cranial ganglia, even when clinical deficits strongly implicate cranial sensory dysfunction in FD ( Mendoza-Santiesteban et al, 2017 ; Barlow, 2009 ; Geltzer et al, 1964 ; Gutiérrez et al, 2015 ; Palma et al, 2018 ; Won et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…transcription) functions ( Dalwadi and Yip, 2018 ; Dietrich and Dragatsis, 2016 ; Lefcort et al, 2017 ). To date, animal studies emphasize defects in dorsal root, sympathetic, and enteric ganglia, which relay sensory and autonomic information from the trunk, limbs, and viscera to the CNS ( Abashidze et al, 2014 ; Cheng et al, 2015 ; George et al, 2013 ; Goffena et al, 2018 ; Hunnicutt et al, 2012 ; Jackson et al, 2014 ; Li et al, 2020 ; Morini et al, 2021 ; Tolman et al, 2022 ). However, there is a dearth of knowledge about Elp1 in the cranial ganglia, even when clinical deficits strongly implicate cranial sensory dysfunction in FD ( Mendoza-Santiesteban et al, 2017 ; Barlow, 2009 ; Geltzer et al, 1964 ; Gutiérrez et al, 2015 ; Palma et al, 2018 ; Won et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…For example, Elp1 may be required for axonal outgrowth via alternative, NGF-independent mechanisms, including anterograde trafficking of receptors for critical growth factors or guidance molecules and/or regulation of local protein synthesis, all of which are required for growing axons ( Scott-Solomon and Kuruvilla, 2018 ; Ascano et al, 2009 ; Cioni et al, 2019 ; Korsak et al, 2016 ; Batista and Hengst, 2016 ; Kang and Schuman, 1996 ). Recently, Elp1 has been shown to regulate neuronal gene expression in a dose-dependent manner in a humanized mouse model of FD ( Morini et al, 2021 ). Importantly, these functions of Elp1 could be direct or indirect via its essential role as part of the elongator complex in modifying tRNAs during translation ( Cameron et al, 2021 ; Chen et al, 2009b ; Chen et al, 2009a ; Goffena et al, 2018 ; Huang et al, 2005 ; Huang et al, 2008 ; Karlsborn et al, 2014 ; Karlsborn et al, 2015 ).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the fact that mutations and/or variants in ELP2-4 , are associated with distinct neurological disorders (albeit with some overlapping features) ranging from intellectual disability to ALS but excluding the sympathetic, sensory, and optic neuropathies exhibited by FD patients, may speak to variation in function of the Elp subunits independent of their joint actions as part of the elongator complex. Although the vast majority of Elp1 is localized to the cytoplasm, there are reports that the elongator complex is also involved in transcriptional elongation (Otero et al 1999; Hawkes et al 2002; Close et al 2006; Morini et al 2021); this effect may be the indirect consequence of changes in the cells’ proteome that occur with loss of elongator function.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the fact that mutations and/or variants in ELP2-ELP4 , are associated with distinct neurological disorders (albeit with some overlapping features), ranging from intellectual disability to amyotrophic lateral sclerosis, but excluding the sympathetic, sensory and optic neuropathies exhibited by FD patients, may indicate variation in function of the Elp subunits independent of their joint actions as part of the Elongator complex. Although the vast majority of Elp1 is localized to the cytoplasm, there are reports that the Elongator complex is also involved in transcriptional elongation ( Otero et al, 1999 ; Hawkes et al, 2002 ; Close et al, 2006 ; Morini et al, 2021 ); this effect may be the indirect consequence of changes in the cells' proteome that occur with loss of Elongator function.…”
Section: Discussionmentioning
confidence: 99%